EDIT — Editas Medicine Share News
0.000.00%
Last trade - 00:00- $382.41m
- $226.51m
- $40.52m
Editas Medicine Inc expected to post a loss of 59 cents a share - Earnings Preview
Editas Medicine Inc expected to post a loss of 58 cents a share - Earnings Preview
Brief: Editas Medicine Announces Chief Financial Officer Transition
Editas Medicine Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Editas Medicine Q4 Net Income USD -45.395 Million
Editas Medicine Inc expected to post a loss of 36 cents a share - Earnings Preview
Editas Medicine Inc expected to post a loss of 36 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Amazon, Ford, Netflix
U.S. RESEARCH ROUNDUP-Amazon, Broadcom, Exxon Mobil
Editas to reduce about 65% of its workforce over the next six months (updated)
Brief: Editas Medicine Announces Strategic Transition To In Vivo Gene Editing Company
Editas to reduce about 65% of its workforce over the next six months
U.S. RESEARCH ROUNDUP-Cigna, Marriott, Ralph Lauren
Editas Medicine Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Editas Medicine Announces Q3 Results And Business Updates
Editas Medicine Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Editas Medicine And Genevant Sciences To Collaborate To Develop Novel Mrna-Lnp Gene Editing Therapeutics
U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Walmart
Editas Medicine Inc reports results for the quarter ended in January - Earnings Summary